(6R)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6R)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one
C44H56F8N16O4 — CID 158980257
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6R)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6R)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one
(6R)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6R)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one (PubChem CID 158980257) has the molecular formula C44H56F8N16O4 and a molecular weight of 1025.02 g/mol. Its IUPAC name is (6R)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6R)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one.
Molecular Properties
| Compound Name | (6R)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6R)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one |
|---|---|
| PubChem CID | 158980257 |
| Molecular Formula | C44H56F8N16O4 |
| Molecular Weight | 1025.02 g/mol |
| Exact Mass | 1024.45 |
| IUPAC Name | (6R)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1S)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6R)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one;(6S)-6-amino-2-[(1R)-2,2-difluorocyclopropyl]-4-methyl-7,8-dihydro-6H-pyrazolo[1,5-a][1,3]diazepin-5-one |
| SMILES | CN1C(=O)[C@@H](N)CCn2nc([C@@H]3CC3(F)F)cc21.CN1C(=O)[C@@H](N)CCn2nc([C@H]3CC3(F)F)cc21.CN1C(=O)[C@H](N)CCn2nc([C@@H]3CC3(F)F)cc21.CN1C(=O)[C@H](N)CCn2nc([C@H]3CC3(F)F)cc21 |
| InChI | InChI=1S/4C11H14F2N4O/c4*1-16-9-4-8(6-5-11(6,12)13)15-17(9)3-2-7(14)10(16)18/h4*4,6-7H,2-3,5,14H2,1H3/t2*6-,7+;2*6-,7-/m1010/s1 |
| InChIKey | JOXFDTYRYNKAPV-VHEDEQSXSA-N |
| XLogP | 2.80 |
| TPSA | 256.60 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 72 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1025.02 |
| LogP ≤ 5 | 2.80 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158980257 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.